Gotowe bibliografie tematyczne / HYPERTENSIVE DRUGS / Książki
Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: HYPERTENSIVE DRUGS.

Książki na temat „HYPERTENSIVE DRUGS”

Autor: Grafiati
Data publikacji: 11 września 2023

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 50 najlepszych książek naukowych na temat „HYPERTENSIVE DRUGS”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj książki z różnych dziedzin i twórz odpowiednie bibliografie.

1

Heart attacks, hypertension, and heart drugs. Emmaus, Pa: Rodale Press, 1987.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

M, Drayer Jan I., Lowenthal David T i Weber Michael A, red. Drug therapy in hypertension. New York: Dekker, 1987.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Switzerland) International Symposium Clonidine in Hypertension (1984 Geneva. Low dose oral and transdermal therapy of hypertension: International Symposium Clonidine in Hypertension, Geneva, 14th-16th June, 1984. Darmstadt: Steinkopff, 1985.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

1947-, Martin John E., i Dubbert Patricia M, red. Non-drug treatments for essential hypertension. New York: Pergamon Press, 1988.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

H, Messerli Franz, i Opie Lionel H, red. Combination drug therapy for hypertension. New York: Author's Pub. House, 1997.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Mann, Samuel J. Hypertension and you: Old drugs, new drugs, and the right drugs for your high blood pressure. Lanham: Rowman & Littlefield Publishers, 2012.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

van, Zwieten P. A., i Greenlee William J, red. Antihypertensive drugs. Amsterdam, the Netherlands: Harwood Academic Publishers, 1997.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

H, Messerli Franz, red. The Heart and hypertension. New York, N.Y: Yorke Medical Books, 1987.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Bönner, Gerd. Prostacyclin and hypertension. Berlin: Springer-Verlag, 1990.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Lower blood pressure without drugs: Curing your hypertension naturally. Wyd. 2. Garden City Park, NY: Square One Publishers, 2012.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
11

Parsont, Wolfson Rita, red. How to control high blood pressure without drugs. New York: Scribner, 1986.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
12

Walter, Flamenbaum, i Punzi Henry A, red. Hypertension. Mount Kisco, NY: Futura Pub. Co., 1989.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
13

Richard, Trubo, red. The H.A.R.T. program: Lower your blood pressure without drugs. New York, N.Y: HarperCollins Publishers, 1992.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
14

Burnier, Michel, red. Drug Adherence in Hypertension and Cardiovascular Protection. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-76593-8.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
15

Toma, Strasser, Ganten D. 1941-, World Health Organization i International Society of Hypertension, red. Mild hypertension: From drug trials to practice. New York: Raven Press, 1987.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
16

Handbook of hypertension. Chichester, West Sussex: Wiley-Blackwell, 2009.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
17

Masaru, Minami, Parvez H i Saitō Hideya 1933-, red. Antihypertensive drugs today. Utrecht, The Netherlands: VSP, 1992.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
18

The DASH diet for hypertension: Lower your blood pressure in 14 days-- without drugs. New York: Gallery Books, 2011.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
19

Moore, Thomas J., M.D., red. The DASH diet for hypertension: Lower your blood pressure in 14 days--without drugs. New York: Pocket Books, 2003.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
20

Arteries in clinical hypertension. Philadelphia: J.B. Lippinott, 1994.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
21

Safar, Michel. Arteries in clinical hypertension. Philadelphia: Lippincott-Raven, 1996.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
22

K, Hollenberg Norman, red. Hypertension: Mechanisms and therapy. Philadelphia: Current Medicine, 1995.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
23

NHS Centre for Reviews & Dissemination., red. Drug treatment of essential hypertension in older people. York: NHS Centre for Reviews and Dissemination, University of York, 1999.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
24

Clinical management of hypertension. Wyd. 6. Caddo, OK: Professonal Communications, 2002.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
25

Parsont, Wolfson Rita, red. How to control high blood pressure without drugs. New York: Ivy Books/Ballantine, 1987.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
26

1937-, Epstein Murray, i Loutzenhiser Rodger, red. Calcium antagonists and the kidney. Philadelphia, PA: Hanley & Belfus, 1990.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
27

Simons, David R. Hypertension: A physician's guide to drug selection and use. Boulder, Colo. (1550 Baseline Rd., Boulder 80302): Keyed Reviews Publications, 1986.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
28

L, Prisant Michael, red. Hypertension in the elderly. Totowa, N.J: Humana Press, 2005.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
29

Canadian Hypertension Society Consensus Conference (1993), red. Guidelines for the treatment of uncomplicated hypertension. Toronto, Canada: Queen's Printer for Ontario, 1995.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
30

Nordmann, Alain Joel. Cost-effectiveness of routine echocardiography in hypertensive patients starting antihypertensive drug therapy. Ottawa: National Library of Canada, 2001.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
31

Igakubu, Hokkaidō Daigaku, red. New advances in antihypertensive drug research: Pathophysiology and pharmacology. Sapporo, Japan: Hokkaido University School of Medicine, 1993.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
32

1933-, Aoki K., i Frohlich Edward D. 1931-, red. Calcium in essential hypertension. Tokyo: Academic Press, 1989.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
33

Hypertension and dyslipidemia management essentials. Sudbury, Mass: Physicians' Press/Jones and Bartlett Publishers, 2010.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
34

1938-, Bennett William M., i McCarron David A, red. Pharmacology and management of hypertension. New York: Churchill Livingstone, 1994.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
35

B, Puschett Jules, i Greenberg Arthur 1950-, red. Diuretics IV: Chemistry, pharmacology, and clinical applications : proceedings of the Fourth International Conference on Diuretics, Boca Raton, Florida, U.S.A., 11-16 October 1992. Amsterdam: Excerpta Medica, 1993.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
36

1942-, Black Henry R., red. Clinical trials in hypertension. New York: Marcel Dekker, 2001.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
37

1938-, Bennett William M., i McCarron David A, red. Pharmacotherapy of renal disease and hypertension. New York: Churchill Livingstone, 1987.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
38

J, Horan Michael, Page Lot B, National Institutes of Health (U.S.) i Workshop on Drug Side Effects, Drug-Drug Interactions, Drug Resistance, and Patient Compliance in the Management of Hypertension (1986 : Bethesda, Md.), red. Drug side effects, drug-drug interactions, drug resistance and patient compliance in the management of hypertension: Bethesda, Maryland, April 28-29 1986. [Dallas, Tex.]: American Heart Association, 1988.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
39

Hypertension management for the primary care clinician. Bethesda, Md: American Society of Health-System Pharmacists, 2004.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
40

Guthrie, Robert M. Pharmacological management of hypertension and dyslipidemia. Sudbury, Mass: Jones and Bartlett Publishers, 2010.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
41

1958-, Böhm M., i Laragh John H. 1924-, red. From hypertension to heart failure. Berlin: Springer, 1998.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
42

Nederfors, Tommy. Xerostomia: Prevalence and pharmacotherapy : with special reference to -adrenoceptor antagonists. [Halmstad]: [Göteborg Univ.], 1996.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
43

Zuckerman, Ilene H. Identifying drug therapy inappropriateness: Determining the validity of drug use review screening criteria. Baltimore, Md: Center on Drugs and Public Policy, School of Pharmacy, University of Maryland at Baltimore, 1997.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
44

1933-, Aoki K., International Symposium on Mechanism and Treatment in Essential Hypertension (1st : 1985 : Nagoya-shi, Japan) i International Symposium on Rats with Spontaneous Hypertension and Related Studies (5th : 1985 : Kyoto, Japan), red. Essential hypertension: Calcium mechanisms and treatment. Tokyo: Springer-Verlag, 1986.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
45

Gidwani, Hitesh, i Chenell Donadee. Hypertensive Emergencies (DRAFT). Redaktorzy Raghavan Murugan i Joseph M. Darby. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190612474.003.0009.

Pełny tekst źródła
Streszczenie:
Hypertensive emergencies may be encountered by rapid response teams (RRTs). Various forms of acute organ dysfunction separate hypertensive urgency from hypertensive emergency. These include acute heart failure, acute coronary syndrome, acute aortic dissection, ischemic stroke, hemorrhagic stroke, hypertensive encephalopathy, sympathetic crisis, postoperative hypertension, and hypertensive emergencies in pregnancy. RRTs must be able to rapidly assess the patient’s condition, initiate treatment, and triage the patient to the appropriate level of care. This chapter summarizes the initial evaluation and triage of the patient as well as the blood pressure reduction goals in the acute period for the various conditions associated with hypertensive emergencies, discussing suggested drugs with the dosages, and looking at common pitfalls.
Style APA, Harvard, Vancouver, ISO itp.
46

Wijdicks, Eelco F. M., i Sarah L. Clark. Antihypertensives and Antiarrhythmics. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190684747.003.0013.

Pełny tekst źródła
Streszczenie:
Acute brain injury can precipitate a hypertensive response, which for the most part is the result of stress-induced, increased sympathetic activity. Acute stroke with hypertension may not be a response but more often a prior, untreated hypertension or a patient with no access to medication. This hypertensive response may wane quickly, and aggressive treatment of these temporary surges in blood pressure could have unwanted consequences. Important characteristics of most antihypertensive drugs used in the neurosciences intensive care unit are cost, having a rapid onset with a short duration of action, and having a low incidence of adverse side effects. Many of the antiarrhythmic drugs also have antihypertensive effects, so these drug classes are best combined in one chapter. This chapter discusses blood pressure targets, the most appropriate antihypertensive medications to use for acute management, and clinically relevant cardiac arrhythmias and their treatment.
Style APA, Harvard, Vancouver, ISO itp.
47

Paneni, Francesco, i Massimo Volpe. Co-morbidity (HFrEF and HFpEF): hypertension. Oxford University Press, 2019. http://dx.doi.org/10.1093/med/9780198784906.003.0415_update_001.

Pełny tekst źródła
Streszczenie:
Hypertensive heart disease is a major cause of heart failure (HF) and mortality. Hypertension precedes HF occurrence in 75% of cases, and carries a sixfold increase in HF risk as compared to non-hypertensive individuals. Most importantly, a minority of patients survive 5 years after the onset of hypertensive HF. In hypertensive patients, the heart may present different patterns of adaptive remodelling: concentric remodelling, concentric hypertrophy, and eccentric hypertrophy. Although most hypertensive patients are at high risk of developing concentric hypertrophy, a growing proportion of subjects display a concentric-to-eccentric progression eventually leading to left ventricular dilation and systolic dysfunction. Several factors including myocardial ischaemia, ethnicity, genetic background, history of diabetes, and blood pressure pattern may significantly influence the pathway from hypertension to left ventricular dilation. Patients with a concentric hypertrophy usually develop HF with preserved ejection fraction (HFpEF), whereas those with an eccentric (dilated) phenotype develop HF with reduced ejection fraction (HFrEF). Lowering blood pressure has a striking effect in reducing the risk of HF. Although available antihypertensive drugs are all successful in lowering blood pressure, angiotensin-converting enzyme inhibitors, angiotensin receptor blocker (ARBs), and diuretics are more effective than other drug classes in preventing HF. The combination of the neprilysin inhibitor sacubitril with the ARB valsartan (LCZ696) has recently been shown to be highly effective in reducing HF-related outcomes in hypertensive subjects. An individualized treatment scheme taking into account blood pressure levels, type of HF (HFpEF or HFrEF), and relevant co-morbidities (i.e. renal disease, diabetes) is currently the best approach to improve morbidity and mortality in hypertensive patients with HF.
Style APA, Harvard, Vancouver, ISO itp.
48

Control High Blood Pressure Without Drugs: A Complete Hypertension Handbook. Fireside, 2001.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
49

Groeneveld, A. B. J., i Alexandre Lima. Vasodilators in critical illness. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199600830.003.0035.

Pełny tekst źródła
Streszczenie:
Vasodilators are commonly used in the intensive care unit (ICU) to control arterial blood pressure, unload the left or the right heart, control pulmonary artery pressure, and improve microcirculatory blood flow. Vasodilator refers to drugs acting directly on the smooth muscles of peripheral vessel walls and drugs are usually classified based on their mechanism (acting directly or indirectly) or site of action (arterial or venous vasodilator). Drugs that have a predominant effect on resistance vessels are arterial dilators and drugs that primarily affect venous capacitance vessels are venous dilators. Drugs that interfere with sympathetic nervous system, block renin-angiotensin system, phosphodiesterase inhibitors, and nitrates are some examples of drugs with indirect effect. Vasodilator drugs play a major therapeutic role in hypertensive emergencies, primary and secondary pulmonary hypertension, acute left heart, and circulatory shock. This review discusses the main types of vasodilators drugs commonly used in the ICU.
Style APA, Harvard, Vancouver, ISO itp.
50

Hyper-Tension and You: Old Drugs, New Drugs and the Right Drugs for Your High Blood Pressure. Rowman & Littlefield Publishers, Incorporated, 2012.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Możesz być także zainteresowany bibliografiami na temat „HYPERTENSIVE DRUGS” dla innych typów źródeł:
Artykuły w czasopismach Rozprawy doktorskie
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!

Do bibliografii